专栏咏竹坊

Chinese Wheelchair Maker Tests U.S. Regulator’s Appetite for Controversial VIE Structure

Jin Medical is first Chinese firm using the variable interest entity (VIE) structure to apply for a New York IPO since the U.S. regulator temporarily banned such listings earlier this year

This article only represents the author's own views.

When it comes to Chinese firms listing in New York, medical IPOs appear to offer the best medicine against controversy.

That’s the message that’s quickly coming through with a trickle of new IPO applications starting to re-emerge on Wall Street, including the latest from wheelchair maker Jin Medical International Ltd. (ZJYL.US). The company made its first public filing for a listing on the Nasdaq in late September, and last Friday filed an updated version that includes a price range and final fundraising targets.

您已阅读9%(569字),剩余91%(5674字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

咏竹坊

咏竹坊(官网链接)提供在香港和美国上市的manbetx3.0 企业相关新闻,重点关注中小企业和筹备上市的公司。

Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.

相关文章

相关话题

设置字号×
最小
较小
默认
较大
最大
分享×